P046 Lenticlair™-ON: An extension trial examining long-term safety and efficacy outcomes associated with an inhaled F/HN-pseudotyped lentiviral vector for CF gene therapy in people with cystic fibrosis.

Autor: Davies, J.C.1,2 (AUTHOR), Mall, M.A.3 (AUTHOR), Polineni, D.4 (AUTHOR), Donaldson, S.H.5 (AUTHOR), Fajac, I.6,7 (AUTHOR), Jain, R.8 (AUTHOR), Rubin, B.K.9 (AUTHOR), Boyd, A.C.10 (AUTHOR), Gill, D.R.11 (AUTHOR), Griesenbach, U.1 (AUTHOR), Hyde, S.C.11 (AUTHOR), McLachlan, G.12 (AUTHOR), Kohlbrenner, V.13 (AUTHOR), Sigmund, R.14 (AUTHOR), Engel, A.15 (AUTHOR), Gupta, A.16 (AUTHOR), Alton, E.1,2 (AUTHOR)
Zdroj: Journal of Cystic Fibrosis. 2024 Supplement 1, Vol. 23, pS80-S80. 1p.
Databáze: Academic Search Ultimate
Externí odkaz: